Alpenglow Biosciences

Alpenglow Biosciences develops the Aurora™ platform, a 3D spatial biology platform using non-destructive 3D imaging and AI to improve predictive diagnostics and intraoperative care. The platform aims to redefine pathology by moving beyond single slide analysis to encompass whole tissue analysis, providing more accurate information for clinicians.

Buy Funded Startups lists

Funding Round:

Funding Amount: $1M

Date: 15-Aug-2024

Investors: Dynamk Capital, Paul McEwan

Markets: Biotechnology, Healthcare, AI, Pathology

HQ: Seattle, Washington, United States

Founded: 2018

Website: https://www.alpenglowbiosciences.com/

LinkedIn: https://www.linkedin.com/company/alpenglow-biosciences

Twitter: https://twitter.com/alpenglowbio

Instagram: